EHMT2 and carcinoma: Overexpression of EHMT2 in distinct carcinomas including esophageal squamous cell carcinoma, hepatocellular carcinoma, aggressive lung cancer, brain cancer, aggressive ovarian cancer and multiple myeloma were observed 51.